AKT1 and head and neck squamous cell carcinoma: Moreover, NVP-TAE226 inhibits the AURKA/AKT/FAK signaling pathway by inhibiting FAK, thereby waning cell invasion and migration in head-and-neck squamous cell carcinoma [19].